Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: Its independence of p53 status

Cancer Science

Volumn 94, Issue 1, 2003, Pages 125-133

  Masunaga, Shin Ichiro ^a   Ono, Koji ^a   Takahashi, Akihisa ^b   Ohnishi, Ken ^b   Ohnishi, Takeo ^b   Suzuki, Minoru ^a   Nagata, Kenji ^a   Kinashi, Yuko ^a   Nagasawa, Hideko ^c   Uto, Yoshihiro ^c   Hori, Hitoshi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CISPLATIN; CYTOCHALASIN B; NICOTINAMIDE; PACLITAXEL; PROTEIN P53; TIRAPAZAMINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL LABELING; CELL PROLIFERATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOKINESIS; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; GAMMA RADIATION; GENE MUTATION; HEAD AND NECK CARCINOMA; HINDLIMB; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INOCULATION; MICRONUCLEUS; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TEMPERATURE SENSITIVITY; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CISPLATIN; COMBINED MODALITY THERAPY; DNA DAMAGE; GAMMA RAYS; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRONUCLEUS TESTS; NEOPLASM PROTEINS; PACLITAXEL; RADIATION-SENSITIZING AGENTS; TRIAZINES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0038662923     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01363.x     Document Type: Article

References (41)

1. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8493-7.
2. Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W, Grosse F. p53 protein exhibits 3′-to-5′ exonuclease activity. Cell 1996; 85: 1089-99.
3. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994; 370: 220-3.
4. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 435-56.
5. Lowe SW. Cancer therapy and p53. Curr Opin Oncol 1995; 7: 547-53.
6. Griffin RJ, Okajima K, Ogawa A, Song CW. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing. Int J Radiat Biol 1999; 75: 1299-306.
7. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-16.
8. Masunaga S, Ono K, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Takagaki M. Augumentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia. Jpn J Cancer Res 1997; 88: 770-7.
9. Masunaga S, Ono K. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res 2002; 43: 11-25.
10. Masunaga S, Ono K, Takahashi A, Ohnishi T, Kinashi Y, Takagaki M. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells. Eur J Cancer 2002; 38: 718-27.
11. Takahashi A. Different inducibility of radiation- or heat-induced p53-dependent apoptosis after acute or chronic irradiation in human cultured squamous cell carcinoma cells. Int J Radiat Biol 2001; 77: 215-24.
12. Ohnishi K, Wang X, Takahashi A, Ohnishi T. Contribution of protein kinase C to p53 dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. Exp Cell Res 1998; 238: 399-406.
13. Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells. Int J Hyperthermia 1999; 15: 7-16.
14. Milross CG, Mason KA, Hunter NR, Terry NHA, Patel N, Harada S, Jibu T, Seong J, Milas L. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. Eur J Cancer 1997; 33: 1299-308.
15. Dorie MJ, Brown JM. Tumor-specific, schedule dependent interaction between tirapazamine (SR 4233) and cisplatin. Cancer Res 1993; 53: 4633-6.
16. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 1991; 127: 308-16.
17. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
18. Seng F, Ley K. Simple synthesis of 3-amino-1,2,4-benzotriazine-1,4-dioxide. Angew Chem Int Ed Engl 1972; 11: 1009-10.
19. Zeman EM, Brown JM, Lemmon MJ, Hirst VK, Lee WW. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys 1986; 12: 1239-42.
20. Nishimura Y, Ono K, Hiraoaka M, Masunaga S, Jo S, Shibamoto Y, Sasai K, Abe M, Iga K, Ogawa Y. Treatment of murine SCCVII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin. Radiat Res 1990; 122: 161-7.
21. Brown JM, Lemmon MJ. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. Cancer Res 1990; 50: 7745-9.
22. Dorie MJ, Brown JM. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine. Cancer Chemother Pharmacol 1997; 39: 361-6.
23. Ota I, Ohnishi K, Takahashi A, Yane K, Kanata H, Miyahara H, Ohnishi T, Hosoi H. Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 495-501.
24. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L, Peters LJ. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 1993; 64: 583-91.
25. Guo GZ, Sasai K, Oya N, Takagi T, Shibuya K, Hiraoka M. Simultaneous evaluation of radiation-induced apoptosis and micronuclei in five cell lines. Int J Radiat Biol 1998; 73: 297-302.
26. Masunaga S, Ono K, Abe M. The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumors. Br J Radiol 1993; 66: 918-26.
27. Masunaga S, Ono K, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M. Alteration of the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures. Int J Hyperthermia 1997; 13: 401-11.
28. Masunaga S, Ono K, Akaboshi M, Nishimura Y, Suzuki M, Kinashi Y, Takagaki M, Hiraoka M, Abe M. Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations. Br J Cancer 1997; 76: 588-93.
29. Masunaga S, Ono K, Suzuki M, Kinashi Y, Takagaki M, Hori H, Kasai S, Nagasawa H, Uto Y. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells. Jpn J Cancer Res 2000; 91: 566-72.
30. Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Kinashi Y, Suzuki M. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low temperature hyperthermia. Radiat Med 1998; 16: 441-8.
31. Masunaga S, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, Hori H, Nagasawa H, Uto Y, Tsuchida I, Sadahiro S, Murayama C. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells. Int J Radiat Oncol Biol Phys 2001; 50: 1063-72.
32. Sigal A, Rotter V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 2000; 60: 6788-93.
33. Roth JA, Swisher SG, Mevn RE. p53 tumor suppressor gene therapy for cancer. Oncology (Huntingt) 1999; 13: 148-54.
34. Jabbur JR, Huang P, Zhang W. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo. Oncogene 2000; 19: 6203-8.
35. Kearsey JM, Shivji MK, Hall PA, Wood RD. Does the p53 up-regulated Gadd45 protein have a role in excision repair? Science 1995; 270: 1004-5. [discussion] 1005-6.
36. Smith MI, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 1994; 266: 1376-80.
37. Szumiel I. Ionizing radiation-induced cell death. Int J Radiat Biol 1994; 66: 329-41.
38. Lowe SW, Ruley HE, Lacks T, Housman DE. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.
39. Tan G, Heqing L, Jiangbo C, Ming J, Yanhong M, Xianqhe L, Hong S, Li G. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Int J Cancer 2002; 97: 168-72.
40. Gandara DR, Lara PN, Goldberg Z, Le QT, Mack PC, Lou DH, Gumerlock PH. Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia. Semin Oncol 2002; 29 (1 Suppl 4): 102-9.
41. Kanata H, Yane K, Ota I, Miyahara H, Matsunaga T, Takahashi A, Ohnishi K, Ohnishi T, Hosoi H. CDDP induced p53-dependent apoptosis in tongue cancer cells. Int J Oncol 2000; 17: 513-7.